Paper Review Records
All Paper Review Records
25 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
Collapsing focal segmental glomerulosclerosis progression to kidney failure following combination therapy with pembrolizumab and enfortumab vedotin: a case report
George Hitti; Caroline Gee; Johnathan Zuckerman; Ramy HannaShow moreShow less
1. School of Medicine, University of California, Irvine, Irvine, USA; 2. Department of Pathology, University of California, Los Angeles, Los Angeles, USA; 3. Department of Nephrology, University of California, Irvine, Orange, USAShow moreShow less
Real-world observational changes in biomarkers and safety profile of finerenone in patients with non-diabetic chronic kidney disease: a systematic review and meta-analysis
Zhe Zhang; Xiaoyi Liu; Peiyi Ye; Yaozhong Kong; Chao XieShow moreShow less
1. The First People’s Hospital of Foshan (Foshan Hospital Affiliated to Southern University of Science and Technology), School of Medicine, Southern University of Science and Technology, Guangdong, ChinaShow moreShow less
CAIGAN study protocol: complement activation in primary IgA nephropathy—study protocol for an international prospective multicenter observational cohort study
Gabriella Guzzo; Manuel Pascual; Francisco M. Herrera-Gomez; Valentin Rousson; Laureane Mittaz-Crettol; Carole Gengler; Hassib Chehade; Andreas D. Kistler; Roberta Fenoglio; Dario Roccatello; Uyen Huynh-Do; Fadi Fakhouri; Daniel TetaShow moreShow less
1. Service of Nephrology, Valais Hospital, Sion, Switzerland; 2. Service of Nephrology and Hypertension, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland; 3. Transplantation Center, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland; 4. Department of Nephrology, Burgos University Hospital, Burgos, Spain; 5. Center for Primary Care and Public Health, University of Lausanne, Lausanne, Switzerland; 6. Genetic Medicine, Department of Laboratory Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland; 7. Institute of Pathology, Department of Laboratory Medicine and Pathology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland; 8. Division of Pediatric Nephrology, Department Woman-Mother-Child, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland; 9. Department of Medicine, Spital Thurgau AG, Frauenfeld, Switzerland and Faculty of Medicine, University of Zurich, Zurich, Switzerland; 10. University Center of Excellence on Nephrological, Rheumatological and Rare Diseases including Nephrology and Dialysis Unit and Center of Immuno-Rheumatology and Rare Diseases, Coordinating Center of the Inter-regional Network for Rare Diseases of Piedmont and Aosta Valley (North-West Italy), San Giovanni Bosco Hub Hospital, ASL Città di Torino, Department of Clinical and Biological Sciences of the University of Turin, Turin, Italy; 11. Division of Nephrology and Hypertension, Inselspital, Bern University Hospital, University of Bern, Bern, SwitzerlandShow moreShow less
Sequential multisystem adverse effects associated with mycophenolate mofetil in a kidney transplant recipient:a case report
Reyhane Motamedifar; Masoumeh Sohrabi; Mahsa PanahishokouhShow moreShow less
1. Department of Nephrology, Isfahan Kidney Disease Research Center, Korshid Hospital, Isfahan University of Medical Sciences, Isfahan, Iran; 2. Department of Clinical Pharmacy and Services, School of Pharmacy, Hamadan University of Medical Sciences, Hamadan, Iran; 3. Department of Clinical Pharmacy and Pharmacy Practice and Pharmaceutical Sciences Research Center, Isfahan University of Medical Sciences, Isfahan, IranShow moreShow less
Early renal adaptation after living kidney donation assessed by multiparametric MRI
Eva Carlsson; Per Liss; Jan Weis; Amir Sedigh; Maria K. SvenssonShow moreShow less
1. Department of Medical Sciences, Renal Medicine, Uppsala University Hospital, Uppsala SE-413 45, Sweden; 2. Department of Surgical Sciences; Radiology, Uppsala University, Uppsala, Sweden; 3. Department of Medical Physics, Uppsala University Hospital, Uppsala, Sweden; 4. Department of Surgical Sciences, Transplantation Surgery, Uppsala University, Uppsala, Sweden; 5. Uppsala Clinical Research Center, Uppsala, SwedenShow moreShow less
Illness experiences, psychosocial problems, and coping processes among individuals with autosomal dominant polycystic kidney disease: a qualitative study
Mesudiye Bulut; Yunus Kaya; Buse Hacıoğlu; Hadim AkoğluShow moreShow less
1. Department of Nephrology, University of Health Sciences, Gülhane Training and Research Hospital, Etlik, Türkiye; 2. Department of Nursing, Faculty of Health Sciences, Aksaray University, Aksaray, TürkiyeShow moreShow less
FAQ
How long does BMC Nephrology take to review a manuscript?
As of 2026-11-19, CrushSCI has 25 complete review records for BMC Nephrology. The fastest paper went from submission to acceptance in 28 days (Efficacy and safety of BAFF/APRIL-pathway inhibitors versus placebo in adults with IgA nephropathy: a systematic review with pairwise and network meta-analysis, received 2026-07-08, accepted 2026-08-05); the slowest took 630 days. The average is 142.7 days and the median is 105 days.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
